- Home
- SKYE vs ESP Comparison
SKYE vs ESP Comparison
Compare SKYE & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- ESP
- Stock Information
- Founded
- SKYE 2012
- ESP 1928
- Country
- SKYE United States
- ESP United States
- Employees
- SKYE N/A
- ESP N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- ESP Industrial Machinery/Components
- Sector
- SKYE Health Care
- ESP Technology
- Exchange
- SKYE Nasdaq
- ESP Nasdaq
- Market Cap
- SKYE 115.9M
- ESP 129.5M
- IPO Year
- SKYE N/A
- ESP N/A
- Fundamental
- Price
- SKYE $3.41
- ESP $46.44
- Analyst Decision
- SKYE Buy
- ESP
- Analyst Count
- SKYE 6
- ESP 0
- Target Price
- SKYE $16.60
- ESP N/A
- AVG Volume (30 Days)
- SKYE 467.4K
- ESP 32.1K
- Earning Date
- SKYE 08-07-2025
- ESP 09-26-2025
- Dividend Yield
- SKYE N/A
- ESP 2.27%
- EPS Growth
- SKYE N/A
- ESP 39.20
- EPS
- SKYE N/A
- ESP 2.67
- Revenue
- SKYE N/A
- ESP $45,965,588.00
- Revenue This Year
- SKYE N/A
- ESP N/A
- Revenue Next Year
- SKYE N/A
- ESP N/A
- P/E Ratio
- SKYE N/A
- ESP $17.37
- Revenue Growth
- SKYE N/A
- ESP 29.60
- 52 Week Low
- SKYE $1.14
- ESP $20.50
- 52 Week High
- SKYE $7.47
- ESP $52.68
- Technical
- Relative Strength Index (RSI)
- SKYE 44.99
- ESP 49.22
- Support Level
- SKYE $3.45
- ESP $41.12
- Resistance Level
- SKYE $3.84
- ESP $52.68
- Average True Range (ATR)
- SKYE 0.35
- ESP 2.72
- MACD
- SKYE -0.12
- ESP -1.02
- Stochastic Oscillator
- SKYE 13.91
- ESP 46.02
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.